Skip to main content
SpringerLink
Log in

Kleinzelliges Lungenkarzinom

Checkpointhemmer zur Chemotherapie bremst auch den Kleinzeller

  • journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Horn L et al. Cancer. N Engl J Med. 2018;379 (23):2220–9

    Article  CAS  Google Scholar 

  2. Sequist LV et al. Ann Oncol. 2016;27(suppl 6):Abstr. 1425PD

    Google Scholar 

  3. Reck M et al. J Clin Oncol. 2016;34(31):3740–8

    Article  CAS  Google Scholar 

  4. Gadgeel SM et al. J Thorac Oncol. 2018;13(9):1392–9

    Article  Google Scholar 

Literatur

  • Horn L et al. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med. 2018;379 (23):2220–9

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik III, Klinikum am Steinenberg / Ermstalklinik, Med. Klinik III Innere Medizin/Pneumologie, Reutlingen-Bad Urach, Deutschland

    Adrian Gillissen (Direktor)

Authors
  1. Adrian Gillissen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrian Gillissen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gillissen, A. Checkpointhemmer zur Chemotherapie bremst auch den Kleinzeller. Info Onkol. 22, 31–32 (2019). https://doi.org/10.1007/s15004-019-6473-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-019-6473-5

Search

Navigation